Journal of Inherited Metabolic Disease

, Volume 27, Issue 2, pp 267–273 | Cite as

Carnitine-acylcarnitine translocase deficiency: Identification of a novel molecular defect in a Bedouin patient

  • D. Galron
  • O. S. Birk
  • A. Kazanovitz
  • S. W. Moses
  • E. Hershkovitz
Article

Abstract

Summary: Carnitine-acylcarnitine translocase CACT deficiency is a very rare autosomal recessive disease. The neonatal phenotype of CACT deficiency is characterized by hypoketotic hypoglycaemia, hyperammonaemia, cardiomyopathy and skeletal muscle weakness culminating in early death. The disease is caused by mutations in the CACT gene, which encodes a protein transporting long-chain fatty acid carnitine esters into the mitochondrial matrix. In this report, we describe the first case of CACT deficiency in the Bedouin population in Israel. The patient, the first son of consanguineous parents, was born at term after uneventful delivery. During the second day of life, he developed clinical signs of an acute metabolic crisis with severe hypoglycaemia and hyperammonaemia. Biochemical investigation suggested the diagnosis of CACT deficiency. Genetic molecular analysis confirmed this diagnosis by demonstrating that the affected child was homozygous for a novel missense mutation 793A>G, substituting glutamine by arginine (Q238R) in exon 7 of the CACT gene. Despite medical treatment and adequate nutrition, the patient died at 6 months of age.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Chalmers RA, Stanley CA, English N, Wigglesworth JS (1997) Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death. J Pediatr 131: 220–225.PubMedCrossRefGoogle Scholar
  2. Costa C, Costa JM, Nuoffer JM, et al (1999) Identification of the molecular defect in a severe case of carnitine-acylcarnitine carrier deficiency. J Inherit Metab Dis 22: 267–270.PubMedCrossRefGoogle Scholar
  3. Hsu BYL, Iacobazzi V, Wang Z, et al (2001) Aberrant mRNA splicing associated with coding region mutations in children with carnitine-acylcarnitine translocase deficiency. Mol Genet Metab 74: 248–255.PubMedCrossRefGoogle Scholar
  4. Huizing M, Iacobazzi V, IJist L, et al (1997) Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient. Am J Hum Genet 61: 1239–1245.PubMedCrossRefGoogle Scholar
  5. Huizing M, Wendel U, Ruitenbeek W, et al (1998) Carnitine-acylcarnitine carrier deficiency: identification of the molecular defect in a patient. J Inherit Metab Dis 21: 262–267.PubMedCrossRefGoogle Scholar
  6. Iacobazzi V, Naglieri MA, Stanley CA, Wanders RJ, Palmieri F (1998) The structure and organization of the human carnitine/acylcarnitine translocase (CACT1) gene2. Biochem Biophys Res Commun 252: 770–774.PubMedCrossRefGoogle Scholar
  7. Indiveri C, Tonazzi A, Prezioso G, Palmieri F (1991) Kinetic characterization of the reconstituted carnitine carrier from rat liver mitochondria. Biochim Biophys Acta 1065: 231–238.PubMedCrossRefGoogle Scholar
  8. Indiveri C, Iacobazzi V, Giangregorio N, Palmieri F (1997) The mitochondrial carnitine carrier protein: cDNA cloning, primary structure and comparison with other mitochondrial transport proteins. Biochem J 321: 713–719.PubMedGoogle Scholar
  9. Manning NJ, Olpin SE, Pollitt RJ, Webley J (1990) A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts. J Inherit Metab Dis 13: 58–68.PubMedCrossRefGoogle Scholar
  10. Morris AA, Olpin SE, Brivet M, Turnbull DM, Jones RA, Leonard JV (1998) A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype. J Pediatr 132: 514–516.PubMedCrossRefGoogle Scholar
  11. Niezen-Koning KE, van Spronsen FJ, Ijlst L, et al (1995) A patient with lethal cardiomyopathy and a carnitine-acylcarnitine translocase deficiency. J Inherit Metab Dis 18: 230–232.PubMedCrossRefGoogle Scholar
  12. Ogawa A, Yamamoto S, Kanazawa M, Takayanagi M, Hasegawa S, Kohno Y (2000) Identification of two novel mutations of the carnitine/acylcarnitine translocase (CACT) gene in a patient with CACT deficiency. J Hum Genet 45: 52–55.PubMedCrossRefGoogle Scholar
  13. Ogier de Baulny H, Slama A, Touati G, Turnbull DM, Pourfarzam M, Brivet M (1995) Neonatal hyperammonemia caused by a defect of carnitine-acylcarnitine translocase. J Pediatr 127: 723–728.PubMedCrossRefGoogle Scholar
  14. Olpin SE, Bonham JR, Downing M, et al (1997) Carnitine-acylcarnitine translocase deficiency-a mild phenotype. J Inherit Metab Dis 20: 714–715.PubMedCrossRefGoogle Scholar
  15. Pande SV (1975) A mitochondrial carnitine acylcarnitine translocase system. Proc Natl Acad Sci USA 72: 883–887.PubMedCrossRefGoogle Scholar
  16. Pande SV, Murthy MSR (1994) Carnitine-acylcarnitine translocase deficiency: implications in human pathology. Biochim Biophys Acta 1226: 269–276.PubMedGoogle Scholar
  17. Rubio-Gozalbo ME, Vos P, Forget PPh, et al (2003) Carnitine-acylcarnitine translocase deficiency: case report and review of the literature Acta Paediatr 92(4): 501–504.PubMedCrossRefGoogle Scholar
  18. Stanley CA, Hale DE, Berry GT, Deleeuw S, Boxer J, Bonnefont J-P (1992) A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. N Engl J Med 327: 19–23.PubMedCrossRefGoogle Scholar
  19. Viggiano L, Iacobazzi V, Marzella R, Cassano C, Rocchi M, Palmieri F (1997) Assignment of the carnitine/acylcarnitine translocase gene (CACT) to human chromosome band 3p21.31 by in situ hybridization. Cytogenet Cell Genet 79: 62–63.PubMedCrossRefGoogle Scholar
  20. Yang BZ, Mallory JM, Roe DS, et al (2001) Carnitine-acylcarnitine translocase deficiency (neonatal phenotype): successful prenatal and postmortem diagnosis associated with a novel mutation in a single family. Mol Genet Metab 73: 64–70.PubMedCrossRefGoogle Scholar
  21. Zierz S, Engel AG (1985) Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle. Eur J Biochem 149: 207–214.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • D. Galron
    • 1
  • O. S. Birk
    • 1
  • A. Kazanovitz
    • 2
  • S. W. Moses
    • 2
  • E. Hershkovitz
    • 3
  1. 1.Genetic Institute and Department of PediatricsSoroka University Medical CenterBeer-ShevaIsrael
  2. 2.Department of PediatricsSoroka University Medical CenterBeer-ShevaIsrael
  3. 3.Department of PediatricsSoroka University Medical CenterBeer-ShevaIsrael

Personalised recommendations